Home » Topics » BioWorld Science

BioWorld Science
RSS

Eisai returns sumatriptan rights to Glaxo Wellcome

May 3, 1996

Xoma, Genentech to collaborate on anti-CD11a

May 3, 1996

Phase III data for Quadramet presented at ASCO

May 3, 1996

Zambon claims (S)-ibuprofen composition

May 3, 1996

Droxidopa studied in patients with chronic pain

May 3, 1996

IGG completes preclinical testing of MMS1

April 26, 1996

Dainippon reports anti-H. pylori compounds

April 26, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

V-411 approved for marketing in China

April 26, 1996

Pulmonary insulin enters phase II

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...